O03: Hydroxocobalamin (OHCbl) dose intensification can prevent visual deterioration and improve neurological and biochemical outcomes in CBLC deficiency
Saved in:
| Main Authors: | Charles Venditti, Jennifer Sloan, Wadih Zein, Audrey Thurm, Camryn Hall, Carol Van Ryzin, Susan Ferry, Abigael Gebremariam, Jennifer Myles, Laryssa Huryn, Brian Brooks, Irini Manoli |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Genetics in Medicine Open |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2949774425000056 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of hydroxocobalamin dosage in patients with CblC deficiency
by: Si Ding, et al.
Published: (2025-08-01) -
P023: Using genomic databases to estimate rare disease prevalence: Application to disorders of propionyl-CoA oxidation
by: Jennifer Sloan, et al.
Published: (2025-01-01) -
Long-term outcome of CblC deficiency complicated with pulmonary hypertension
by: Si Ding, et al.
Published: (2025-06-01) -
Hydroxocobalamin for the treatment of vasoplegia after lung transplantation: A case series
by: Anh Nguyen, MD, PhD, et al.
Published: (2025-02-01) -
Acute Cyanide Poisoning: Hydroxocobalamin and Sodium Thiosulfate Treatments with Two Outcomes following One Exposure Event
by: Andrew Meillier, et al.
Published: (2015-01-01)